Both in Pharmaceuticals
Bausch Health Companies vs IDEAYA Biosciences
Over the past year BHC returned +23.3% and IDYA returned +1.5%; their daily moves had a correlation of 0.07.
BHC +23.3% IDYA +1.5%Growth of $1, one year, split-adjusted
| Metric | BHC | IDYA |
|---|---|---|
| Price | $8.40 | $31.84 |
| Market cap | $3.14B | $3.07B |
| Today | +3.13% | +1.63% |
| 1 month | +39.5% | −13.1% |
| 6 months | +48.6% | +10.8% |
| Year to date | +20.8% | −7.9% |
| 1 year | +23.3% | +1.5% |
| Revenue growth (YoY) | +9.7% | −95.1% |
| Gross margin | 75.0% | 100.0% |
| Net margin | 14.8% | −1227.8% |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 84.1× |
| Net cash | -$18.15B | $838.5M |
| Dividend yield | — | — |
| Volatility (60d) | 67.9% | 37.2% |
| Short % of float | 3.1% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).